OR21-6 AZP-3601, a Long-Acting Parathyroid Hormone (PTH) Analog, Normalizes Blood Calcium in Thyroparathyroidectomized (TPTX) Rats Without Causing Deleterious Changes in Bone

甲状旁腺激素 内科学 内分泌学 医学 钙 化学
作者
Michael D. Culler,Thomas J. Gardella,Çağrı Aksu
出处
期刊:Journal of the Endocrine Society [Endocrine Society]
卷期号:6 (Supplement_1): A196-A196 被引量:1
标识
DOI:10.1210/jendso/bvac150.403
摘要

Abstract PTH peptides can be effective in normalizing blood calcium (Ca++) levels in cases of hypoparathyroidism (HP), but long-term effects on bone are not well understood. AZP-3601 is a long-acting PTH/PTHrP(1-36) analog currently being investigated as a potential treatment option for HP. As compared to conventional PTH1-34, AZP-3601 binds with higher affinity to the R0 conformation of the PTH receptor and thereby induces more sustained signaling responses in cells as well as more prolonged calcemic responses in vivo, despite having a very short circulating half-life. Using the TPTX rat model of HP, we investigated whether the distinct mode-of-action used by AZP-3601 results in different down-stream effects in bone than those induced by PTH1-34, when the peptides are administered long-term (31 days) either by daily sc injection (AZP-3601 and PTH1-34) or by continuous infusion (PTH1-34), and at doses aimed to optimally normalize blood Ca++ levels. Methods Male TPTX rats (strain S-D, age 9 weeks, and 2 weeks post TPTX surgery) were injected daily with either AZP-3601 at a dose of 0.7 nmol/kg or PTH1-34 at a dose of 50 nmol/kg, or were continuously infused via Alzet mini-pump with PTH1-34 at a dose of 3.0 nmol/kg/day. Vehicle treatments and sham surgery rats were used as controls. Tail-vein blood was collected on days 1, 7 14, 21 and 28 at 6 hours post-injection and analyzed for total Ca++. Rats were euthanized on day 31 (24 hours after last injection) and blood and femurs collected for analysis. Results All peptide-treatments increased serum Ca++ levels on days 7-21 to within or near the normal range (8.8-11.7 mg/dL versus 10.8-11.9 mg/dL in sham-operated rats) and to levels significantly higher than those in vehicle-treated TPTX rats (6.9-7.9 mg/dL, P<0.01). Bone mCT analysis revealed that relative to TPTX-vehicle controls, PTH1-34 continuous infusion significantly decreased (p<0.001) distal femur trabecular bone volume relative to tissue volume (BV/TV), trabecular number (Tb.N) and trabecular thickness (Tb.Th), while PTH1-34 daily injection significantly increased (P<0.001) distal femur BV/TV, Tb.Th and Tb.N, as well as mid-femur cortical thickness (Ct.Th, P<0.001). In contrast, AZP-3601 daily injection caused no change in trabecular or cortical bone parameters. Serum levels of the bone formation marker P1NP were significantly increased by daily injection of PTH1-34 (P<0.001 vs. TPTX-vehicle) but were not changed by other treatments. Conclusion With long-term (31 days) treatment and at doses that similarly normalized serum Ca++ in TPTX rats, effects on bone were catabolic for PTH1-34 by continuous infusion, anabolic for PTH1-34 by daily injection, and neutral for AZP-3601 by daily injection. The distinct MOA used by AZP-3601 may thus result in less of an impact on bone than either daily injection or sustained, continuous delivery of PTH(1-34), when used as a long-term treatment for HP. Presentation: Monday, June 13, 2022 12:15 p.m. - 12:30 p.m.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
wb完成签到,获得积分20
刚刚
怡然绿蝶完成签到,获得积分10
刚刚
依依完成签到,获得积分10
1秒前
zerolake发布了新的文献求助10
1秒前
harry完成签到,获得积分10
1秒前
情绪稳定完成签到 ,获得积分10
2秒前
拓荒者完成签到,获得积分10
2秒前
coozrasimon发布了新的文献求助30
2秒前
3秒前
重要的问玉完成签到,获得积分10
3秒前
5秒前
绝世大魔王完成签到 ,获得积分10
6秒前
xiao完成签到 ,获得积分10
6秒前
拓荒者发布了新的文献求助10
6秒前
6秒前
西溪发布了新的文献求助10
6秒前
123432完成签到,获得积分10
7秒前
丁丁当当发布了新的文献求助30
7秒前
清脆的坤发布了新的文献求助10
8秒前
8秒前
早日毕业完成签到,获得积分10
9秒前
科研通AI6.4的应助被yyyyy采纳,获得10
10秒前
moonriver完成签到 ,获得积分10
10秒前
xxx完成签到 ,获得积分10
10秒前
研友_VZG7GZ的应助被讨厌鬼采纳,获得10
12秒前
wb关注了科研通微信公众号
13秒前
13秒前
smile完成签到,获得积分10
13秒前
运气不错发布了新的文献求助10
14秒前
嘻嘻哈哈的应助被Liu采纳,获得10
16秒前
无花果的应助被Huang采纳,获得10
16秒前
16秒前
qianhao完成签到,获得积分10
16秒前
17秒前
Kia完成签到,获得积分20
18秒前
柠溪完成签到 ,获得积分10
19秒前
20秒前
寒冷怜南发布了新的文献求助10
20秒前
20秒前
瓅芩发布了新的文献求助10
20秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology)求助 1000
Encyclopedia of Modern Artificial Intelligence 1000
John McDowells Bildungstheorie 800
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
Synthesis, Application and Future Perspectives of Smart Nano-materials - Part 1 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8153509
求助须知:如何正确求助?哪些是违规求助? 9550216
关于积分的说明 21697167
捐赠科研通 7742065
什么是DOI,文献DOI怎么找? 3425525
关于科研通互助平台的介绍 2550636
邀请新用户注册赠送积分活动 2469175